Outsourcing Becoming Commonplace for Big Pharma

Outsourcing can no longer be regarded as the wave of the future. At least in the case of the Pharmaceutical-Biotech Industry, the practice of utilizing contract manufacturing organizations (CMOs) and contract research organizations (CROs) has become commonplace.